Enveric Biosciences, Inc.
ENVB · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $2,241 | $2,288 | $17,724 | $17,356 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $225 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $494 | $1,069 | $708 | $381 |
| Total Curr. Assets | $2,735 | $3,582 | $18,432 | $17,737 |
| Property Plant & Equip (Net) | $306 | $507 | $741 | $471 |
| Goodwill | $0 | $0 | $0 | $1,588 |
| Intangibles | $42 | $211 | $380 | $6,924 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | -$0 | -$0 |
| Total NC Assets | $348 | $718 | $1,121 | $8,982 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $3,083 | $4,300 | $19,553 | $26,719 |
| Liabilities | – | – | – | – |
| Payables | $522 | $1,219 | $463 | $683 |
| Short-Term Debt | $0 | $0 | $64 | $107 |
| Tax Payable | $261 | $22 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $707 | $1,102 | $3,469 | $1,293 |
| Total Curr. Liab. | $1,490 | $2,344 | $3,996 | $2,084 |
| LT Debt | $0 | $0 | $0 | $69 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | -$0 | $2,261 |
| Total NC Liab. | $0 | $0 | -$0 | $2,330 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $64 | $176 |
| Total Liabilities | $1,490 | $2,344 | $3,996 | $4,413 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $7 | $27 | $21 | $7 |
| Retained Earnings | -$106,075 | -$96,500 | -$79,208 | -$60,736 |
| AOCI | -$595 | -$570 | -$537 | -$31 |
| Other Equity | $108,255 | $98,998 | $94,396 | $83,067 |
| Total Equity | $1,593 | $1,956 | $14,672 | $22,306 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $885 | $0 |
| Total Liab. & Tot. Equity | $3,083 | $4,300 | $19,553 | $26,719 |
| Net Debt | -$2,241 | -$2,288 | -$17,660 | -$17,180 |